dRx Capital Information

dRx Capital backs exceptional entrepreneurs transforming healthcare through data and digital technology. The fund, backed by Novartis, invests in technology platforms improving access to healthcare and reimagining the practice of medicine, with a focus on AI & ML, big data, R&D optimization, patient care, and pharma supply chain and commercialization. dRx Capital currently has 25+ portfolio companies, including: Aktana, Animantis, Aspen RxHealth, Cala Health, Cota Health, Flywheel, Freenome, H1, Koneksa, Mekonos, NuvoAir, Omada, Pear Therapeutics, Peptone, RxVantage, SchoolCare, Science 37, SomaLogic, Vineti, Xealth.

Website	https://drxcapital.com/
Revenue	$4 million
Employees	9 (1 on RocketReach)
Founded	2015
Address	44 Montgomery St, 44 Montgomery St, San Francisco, California 94104, US
Technologies	HTML , Twitter , Nginx +10 more (view full list)
Industry	Venture Capital and Private Equity Principals, Finance General, Financial Services, Venture Capital, Finance, Digital Health, Digital Medicine
Keywords	Healthcare Technology, Medtech Startups, Digital Health, Data Driven Healthcare, Digital Therapeutics, Healthcare Innovation, Telemedicine Technology, Medical Technology Investment, Remote Patient Monitoring, Health Tech Venture Capital, Healthcare Data Analytics, Healthcare Venture Fund, Medical Data Platform, Biotechnology Investment, Healthcare Access, Pharmaceutical Investment, Improving Healthcare Access, Transforming Healthcare
Competitors	Scripps Health, Bainbridge Health, NovaQuest Capital Management, Gaia Inc., Cureatr, Health Catalyst, Aetion, Zylo, Fathom, Clarify Health Solutions +44 more (view full list)
SIC	SIC Code 67 Companies, SIC Code 679 Companies
NAICS	NAICS Code 523 Companies, NAICS Code 5239 Companies, NAICS Code 52 Companies